You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

FOMEPIZOLE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Fomepizole

A generic version of FOMEPIZOLE was approved as fomepizole by AM REGENT on December 14th, 2007.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FOMEPIZOLE?
  • What are the global sales for FOMEPIZOLE?
  • What is Average Wholesale Price for FOMEPIZOLE?
Drug patent expirations by year for FOMEPIZOLE
Drug Prices for FOMEPIZOLE

See drug prices for FOMEPIZOLE

Recent Clinical Trials for FOMEPIZOLE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Richard Dart, MD, PhDPhase 2
Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare DivisionPhase 2
University of ArizonaEarly Phase 1

See all FOMEPIZOLE clinical trials

Pharmacology for FOMEPIZOLE
Drug ClassAntidote
Anatomical Therapeutic Chemical (ATC) Classes for FOMEPIZOLE
Paragraph IV (Patent) Challenges for FOMEPIZOLE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ANTIZOL Injection fomepizole 1.5 g/1.5 mL 020696 1 2021-11-01
ANTIZOL Injection fomepizole 1.5 g/1.5 mL 020696 1 2014-04-14

US Patents and Regulatory Information for FOMEPIZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Regent FOMEPIZOLE fomepizole INJECTABLE;INJECTION 078368-001 Dec 14, 2007 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan Institutional FOMEPIZOLE fomepizole INJECTABLE;INJECTION 078639-001 Mar 3, 2008 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Gland Pharma Ltd FOMEPIZOLE fomepizole INJECTABLE;INJECTION 216791-001 Jul 6, 2023 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.